Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Borean Pharma buys Proteopharma

Executive Summary

Borean Pharma AS (recombinant protein technology for drug development) has acquired Proteopharma AS, including patents covering a trimerized apolipoprotein A-I (ApoA-I) the two companies were developing to reduce arterial cholesterol plaque and prevent blood clots.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register